4th Quarter - Report

VERTEX PHARMACEUTICALS INCORPORATED for VERTEX PHARMACEUTICALS INCORPORATED

Firm
Client
Income
—
Expenses
$920,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

General education about federal policies impacting pharmaceutical development, approval, and reimbursement; Patient access to non-opioid pain medicines; Issues related to FDA drug approval process; Copay accumulators and maximizers, HELP Copays Act (H.R. 830/S. 1375); General education about Alternative Funding Programs; Pandemic All-Hazards Preparedness Act reauthorization, including new authorities requested by FDA.

LobbyistCovered position, as disclosed
HANNAH BETH CORNWELL —
ERIN MENDELSOHN New LD, Rep Eshoo (Jan 2013 - May 2015); Congressional Liaison - FDA (May 2015 - Feb 2018); Rep. Harman - Staff Assistant (Jun 2005 - Jun 2006); Rep. Eshoo - Leg. Correspondent, Leg. Assistant, Senior Leg. Assistant (Jan 2005 - Jan 2013).
KRISTIN RICHTER —
MATTHEW O SCHUMAKER —
SWARNA VALLURUPALLI —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1375 (118th), H.R. 830 (118th)

Taxation/Internal Revenue Code TAX

Issues related to corporate and international tax policy and research and development tax credits, American Innovation and R&D Competitiveness Act (H.R. 2673) and American Innovation and Jobs Act (S. 866)

LobbyistCovered position, as disclosed
MATTHEW O SCHUMAKER —
SWARNA VALLURUPALLI —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2673 (118th), S. 866 (118th)

Medicare/Medicaid MMM

General education about federal policies impacting pharmaceutical development, approval, and reimbursement; Implementation of P.L. 117-169 provisions related to Medicare prescription drugs; Education about non-opioid pain therapies and Medicare beneficiary access to non-opioid medicines; Medicaid Program; Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program.

LobbyistCovered position, as disclosed
HANNAH BETH CORNWELL —
ERIN MENDELSOHN New LD, Rep Eshoo (Jan 2013 - May 2015); Congressional Liaison - FDA (May 2015 - Feb 2018); Rep. Harman - Staff Assistant (Jun 2005 - Jun 2006); Rep. Eshoo - Leg. Correspondent, Leg. Assistant, Senior Leg. Assistant (Jan 2005 - Jan 2013).
KRISTIN RICHTER —
MATTHEW O SCHUMAKER —
SWARNA VALLURUPALLI —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.